Farkas Szabolcs

Farkas, S., Nagy, K., Palkovits, M., Kovács, G. G., Jia, Z., Donohue, S., Pike, V., Halldin, C., Máthé, D., Harkány, T., Gulyás, B., Csiba, L.: [125I]SD-7015 reveals fine modalities of CB1 cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's disease.
Neurochem. Int. 60 (3), 286-291, 2012.

Farkas, S., Molnár, S., Nagy, K., Hortobágyi, T., Csiba, L.: Comparative in vivo and in vitro postmortem ultrasound assessment of intima-media thickness with additional histological analysis in human carotid arteries.
In: Perspectives in Medicine : New Trends in Neurosonology and Cerebral Hemodynamics - an Update Vol.1. Eds.: Eva Bartels, Susanne Bartels, Holger Poppert, Elsevier, Amsterdam, 170-176, 2012.

Farkas, S., Nagy, K., Jia, Z., Hortobágyi, T., Varrone, A., Halldin, C., Csiba, L., Gulyás, B.: Signal transduction pathway activity compensates dopamine D2/D3 receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [3H]raclopride and [35S]GTPgammaS.
Brain Res. 1453, 56-63, 2012.

Farkas, S., Nagy, K., Jia, Z., Harkány, T., Palkovits, M., Donohue, S., Pike, V., Halldin, C., Máthé, D., Csiba, L., Gulyás, B.: The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D2/D3 antagonist [3H]raclopride and the novel CB1 inverse agonist [125I]SD7015.
Brain Res. Bull. 87 (6), 504-510, 2012.

Csiba, L., Farkas, S., Kollár, J., Berényi, E., Nagy, K., Bereczki, D.: Visualization of the ischemic core on native human brain slices by potassium staining method.
J. Neurosci. Methods. 192 (1), 17-21, 2010.

Csiba, L., Farkas, S.: How do stroke units enhance stroke recovery?.
Exp. Rev. Neurother. 9 (4), 431-434, 2009.